George Goldsmith, Chief Executive Officer of COMPASS Pathways PLC (NASDAQ:CMPS) joins James west to discuss Psycadelics approval in Canada.
Several years ago co-founders, George Goldsmith and Ekaterina Malievskaia, experienced the painful effects of depression within their own family. They discovered first-hand how hard it can be to find adequate mental health care for a loved one, and met many other patients and families who felt similarly helpless.
Motivated to find a new approach to mental health care, together with third co-founder Lars Christian Wilde, they started COMPASS with a commitment to putting patients at the heart of the company’s purpose.
Compass Pathways’ develop clinical research programme using recommended scientific processes from regulatory agencies. Their goal is to collaborate with others to advance science that could lead to improved patient outcomes and ensure their therapies are accessible and affordable to all who might be helped by them.